Zhao X, Zhang M, Li H, Lu S
Institute of Medicinal Biotechnology, CAMS, Beijing.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Aug;17(4):248-52.
We here replaced the cell-binding domain in Pseudomonas exotoxin A (PE) with HIV-binding portion of CD4V1V2 molecule and constructed a chimeric gene CD4V1V2-PE40, which can be expressed in E. coli. The hybrid protein displays targeting toxicity toward cells infected by HIV and thus represents a promising novel therapeutic agent for the treatment of AIDS.
我们在此将绿脓杆菌外毒素A(PE)中的细胞结合结构域替换为CD4V1V2分子的HIV结合部分,并构建了嵌合基因CD4V1V2-PE40,该基因可在大肠杆菌中表达。这种杂合蛋白对受HIV感染的细胞具有靶向毒性,因此是一种有前景的治疗艾滋病的新型治疗剂。